Geron reported $116.64M in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
Amgen USD 6.22B 121M Dec/2025
Bio Techne USD 205.45M 2.26M Dec/2025
Cytokinetics USD 0 0 Dec/2023
Esperion Therapeutics USD 108.54M 5.93M Sep/2025
Exelixis USD 27.4M 3.92M Sep/2025
Genmab DKK 13M 1000K Jun/2025
Geron USD 116.64M 21.21M Dec/2025
Gilead Sciences USD 1.78B 40M Sep/2025
Incyte USD 101.06M 17.61M Dec/2025
MacroGenics USD 8.75M 530K Sep/2025
Novartis USD 6.42B 114M Sep/2025
Novavax USD 11.54M 1.97M Dec/2025